Acumen Pharmaceuticals Inc
(NASDAQ:ABOS)
$4.25
0.08[1.92%]
Last update: 8:45AM (Delayed 15-Minutes)
Get Real Time Here
$4.25
0[0.00%]
Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News Summary

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.360-0.280 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-09Credit SuisseJudah FrommerReiteratesOutperformOutperformMaintains-13.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-07-20B of A SecuritiesGeoff MeachamReinstatesBuyAnnounces-14.00
2023-07-17Cantor FitzgeraldPete StavropoulosReiteratesOverweightOverweightMaintains-13.00

Related Companies

TickerCompanyChg %Mkt Cap
ABOSAcumen Pharmaceuticals1.92%245.9M
RENBRenovaro Biosciences4.42%270.7M
IPHAInnate Pharma-4.17%203.7M
INZYInozyme Pharma-0.59%259.3M
IMRXImmuneering-1.92%224.7M
Q

How do I buy Acumen Pharmaceuticals (ABOS) stock?

A

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acumen Pharmaceuticals's (ABOS) competitors?

Q

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

A

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by Credit Suisse on Wednesday, August 9, 2023. The analyst firm set a price target for 13.00 expecting ABOS to rise to within 12 months (a possible 205.88% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

A

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $4.25 last updated September 29, 2023 at 12:45 PM UTC.

Q

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

A

There is no dividend information for Acumen Pharmaceuticals.

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is Acumen Pharmaceuticals (ABOS) going to split?

A

There is no upcoming split for Acumen Pharmaceuticals.

Q

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

A

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News Summary

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.360-0.280 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-09Credit SuisseJudah FrommerReiteratesOutperformOutperformMaintains-13.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-07-20B of A SecuritiesGeoff MeachamReinstatesBuyAnnounces-14.00
2023-07-17Cantor FitzgeraldPete StavropoulosReiteratesOverweightOverweightMaintains-13.00

Related Companies

TickerCompanyChg %Mkt Cap
ABOSAcumen Pharmaceuticals1.92%245.9M
RENBRenovaro Biosciences4.42%270.7M
IPHAInnate Pharma-4.17%203.7M
INZYInozyme Pharma-0.59%259.3M
IMRXImmuneering-1.92%224.7M
Q

How do I buy Acumen Pharmaceuticals (ABOS) stock?

A

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acumen Pharmaceuticals's (ABOS) competitors?

Q

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

A

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by Credit Suisse on Wednesday, August 9, 2023. The analyst firm set a price target for 13.00 expecting ABOS to rise to within 12 months (a possible 205.88% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

A

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $4.25 last updated September 29, 2023 at 12:45 PM UTC.

Q

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

A

There is no dividend information for Acumen Pharmaceuticals.

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is Acumen Pharmaceuticals (ABOS) going to split?

A

There is no upcoming split for Acumen Pharmaceuticals.

Q

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

A

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News Summary

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.360-0.280 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-09Credit SuisseJudah FrommerReiteratesOutperformOutperformMaintains-13.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-07-20B of A SecuritiesGeoff MeachamReinstatesBuyAnnounces-14.00
2023-07-17Cantor FitzgeraldPete StavropoulosReiteratesOverweightOverweightMaintains-13.00

Related Companies

TickerCompanyChg %Mkt Cap
ABOSAcumen Pharmaceuticals1.92%245.9M
RENBRenovaro Biosciences4.42%270.7M
IPHAInnate Pharma-4.17%203.7M
INZYInozyme Pharma-0.59%259.3M
IMRXImmuneering-1.92%224.7M
Q

How do I buy Acumen Pharmaceuticals (ABOS) stock?

A

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acumen Pharmaceuticals's (ABOS) competitors?

Q

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

A

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by Credit Suisse on Wednesday, August 9, 2023. The analyst firm set a price target for 13.00 expecting ABOS to rise to within 12 months (a possible 205.88% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

A

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $4.25 last updated September 29, 2023 at 12:45 PM UTC.

Q

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

A

There is no dividend information for Acumen Pharmaceuticals.

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is Acumen Pharmaceuticals (ABOS) going to split?

A

There is no upcoming split for Acumen Pharmaceuticals.

Q

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

A

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News Summary

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.360-0.280 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-09Credit SuisseJudah FrommerReiteratesOutperformOutperformMaintains-13.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-07-20B of A SecuritiesGeoff MeachamReinstatesBuyAnnounces-14.00
2023-07-17Cantor FitzgeraldPete StavropoulosReiteratesOverweightOverweightMaintains-13.00

Related Companies

TickerCompanyChg %Mkt Cap
ABOSAcumen Pharmaceuticals1.92%245.9M
RENBRenovaro Biosciences4.42%270.7M
IPHAInnate Pharma-4.17%203.7M
INZYInozyme Pharma-0.59%259.3M
IMRXImmuneering-1.92%224.7M
Q

How do I buy Acumen Pharmaceuticals (ABOS) stock?

A

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acumen Pharmaceuticals's (ABOS) competitors?

Q

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

A

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by Credit Suisse on Wednesday, August 9, 2023. The analyst firm set a price target for 13.00 expecting ABOS to rise to within 12 months (a possible 205.88% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

A

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $4.25 last updated September 29, 2023 at 12:45 PM UTC.

Q

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

A

There is no dividend information for Acumen Pharmaceuticals.

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is Acumen Pharmaceuticals (ABOS) going to split?

A

There is no upcoming split for Acumen Pharmaceuticals.

Q

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

A

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News Summary

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.360-0.280 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-09Credit SuisseJudah FrommerReiteratesOutperformOutperformMaintains-13.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-07-20B of A SecuritiesGeoff MeachamReinstatesBuyAnnounces-14.00
2023-07-17Cantor FitzgeraldPete StavropoulosReiteratesOverweightOverweightMaintains-13.00

Related Companies

TickerCompanyChg %Mkt Cap
ABOSAcumen Pharmaceuticals1.92%245.9M
RENBRenovaro Biosciences4.42%270.7M
IPHAInnate Pharma-4.17%203.7M
INZYInozyme Pharma-0.59%259.3M
IMRXImmuneering-1.92%224.7M
Q

How do I buy Acumen Pharmaceuticals (ABOS) stock?

A

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acumen Pharmaceuticals's (ABOS) competitors?

Q

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

A

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by Credit Suisse on Wednesday, August 9, 2023. The analyst firm set a price target for 13.00 expecting ABOS to rise to within 12 months (a possible 205.88% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

A

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $4.25 last updated September 29, 2023 at 12:45 PM UTC.

Q

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

A

There is no dividend information for Acumen Pharmaceuticals.

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is Acumen Pharmaceuticals (ABOS) going to split?

A

There is no upcoming split for Acumen Pharmaceuticals.

Q

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

A

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News Summary

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.360-0.280 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-09Credit SuisseJudah FrommerReiteratesOutperformOutperformMaintains-13.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-07-20B of A SecuritiesGeoff MeachamReinstatesBuyAnnounces-14.00
2023-07-17Cantor FitzgeraldPete StavropoulosReiteratesOverweightOverweightMaintains-13.00

Related Companies

TickerCompanyChg %Mkt Cap
ABOSAcumen Pharmaceuticals1.92%245.9M
RENBRenovaro Biosciences4.42%270.7M
IPHAInnate Pharma-4.17%203.7M
INZYInozyme Pharma-0.59%259.3M
IMRXImmuneering-1.92%224.7M
Q

How do I buy Acumen Pharmaceuticals (ABOS) stock?

A

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acumen Pharmaceuticals's (ABOS) competitors?

Q

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

A

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by Credit Suisse on Wednesday, August 9, 2023. The analyst firm set a price target for 13.00 expecting ABOS to rise to within 12 months (a possible 205.88% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

A

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $4.25 last updated September 29, 2023 at 12:45 PM UTC.

Q

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

A

There is no dividend information for Acumen Pharmaceuticals.

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is Acumen Pharmaceuticals (ABOS) going to split?

A

There is no upcoming split for Acumen Pharmaceuticals.

Q

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

A

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News Summary

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.360-0.280 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-09Credit SuisseJudah FrommerReiteratesOutperformOutperformMaintains-13.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-07-20B of A SecuritiesGeoff MeachamReinstatesBuyAnnounces-14.00
2023-07-17Cantor FitzgeraldPete StavropoulosReiteratesOverweightOverweightMaintains-13.00

Related Companies

TickerCompanyChg %Mkt Cap
ABOSAcumen Pharmaceuticals1.92%245.9M
RENBRenovaro Biosciences4.42%270.7M
IPHAInnate Pharma-4.17%203.7M
INZYInozyme Pharma-0.59%259.3M
IMRXImmuneering-1.92%224.7M
Q

How do I buy Acumen Pharmaceuticals (ABOS) stock?

A

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acumen Pharmaceuticals's (ABOS) competitors?

Q

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

A

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by Credit Suisse on Wednesday, August 9, 2023. The analyst firm set a price target for 13.00 expecting ABOS to rise to within 12 months (a possible 205.88% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

A

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $4.25 last updated September 29, 2023 at 12:45 PM UTC.

Q

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

A

There is no dividend information for Acumen Pharmaceuticals.

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is Acumen Pharmaceuticals (ABOS) going to split?

A

There is no upcoming split for Acumen Pharmaceuticals.

Q

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

A

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News Summary

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.360-0.280 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-09Credit SuisseJudah FrommerReiteratesOutperformOutperformMaintains-13.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-07-20B of A SecuritiesGeoff MeachamReinstatesBuyAnnounces-14.00
2023-07-17Cantor FitzgeraldPete StavropoulosReiteratesOverweightOverweightMaintains-13.00

Related Companies

TickerCompanyChg %Mkt Cap
ABOSAcumen Pharmaceuticals1.92%245.9M
RENBRenovaro Biosciences4.42%270.7M
IPHAInnate Pharma-4.17%203.7M
INZYInozyme Pharma-0.59%259.3M
IMRXImmuneering-1.92%224.7M
Q

How do I buy Acumen Pharmaceuticals (ABOS) stock?

A

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acumen Pharmaceuticals's (ABOS) competitors?

Q

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

A

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by Credit Suisse on Wednesday, August 9, 2023. The analyst firm set a price target for 13.00 expecting ABOS to rise to within 12 months (a possible 205.88% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

A

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $4.25 last updated September 29, 2023 at 12:45 PM UTC.

Q

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

A

There is no dividend information for Acumen Pharmaceuticals.

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is Acumen Pharmaceuticals (ABOS) going to split?

A

There is no upcoming split for Acumen Pharmaceuticals.

Q

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

A

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News Summary

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open4.220Close4.150
Vol / Avg.229.963K / 1.113MMkt Cap245.941M
Day Range4.110 - 4.23052 Wk Range3.520 - 11.310
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.360-0.280 0.0800
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-09Credit SuisseJudah FrommerReiteratesOutperformOutperformMaintains-13.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-15.00
2023-07-20B of A SecuritiesGeoff MeachamReinstatesBuyAnnounces-14.00
2023-07-17Cantor FitzgeraldPete StavropoulosReiteratesOverweightOverweightMaintains-13.00

Related Companies

TickerCompanyChg %Mkt Cap
ABOSAcumen Pharmaceuticals1.92%245.9M
RENBRenovaro Biosciences4.42%270.7M
IPHAInnate Pharma-4.17%203.7M
INZYInozyme Pharma-0.59%259.3M
IMRXImmuneering-1.92%224.7M
Q

How do I buy Acumen Pharmaceuticals (ABOS) stock?

A

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acumen Pharmaceuticals's (ABOS) competitors?

Q

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

A

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by Credit Suisse on Wednesday, August 9, 2023. The analyst firm set a price target for 13.00 expecting ABOS to rise to within 12 months (a possible 205.88% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

A

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $4.25 last updated September 29, 2023 at 12:45 PM UTC.

Q

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

A

There is no dividend information for Acumen Pharmaceuticals.

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is Acumen Pharmaceuticals (ABOS) going to split?

A

There is no upcoming split for Acumen Pharmaceuticals.

Q

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

A

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.